Veterans have played an unusually visible role in the modern psychedelic-therapy conversation, particularly through advocacy and research surrounding MDMA-assisted therapy for PTSD. That focus makes sense, but veteran mental health is much broader than post-traumatic stress disorder alone.
Depression, anxiety, grief, substance use, chronic pain, sleep problems, relationship difficulties, and what clinicians sometimes describe as moral injury can all affect veterans after military service. Researchers are increasingly interested in whether psychedelic-assisted therapies could eventually have roles in some of these areas as well.
Why PTSD Became the Starting Point
PTSD was an obvious early focus because trauma can be severe, persistent, and difficult to treat for some people. MDMA-assisted psychotherapy became especially associated with PTSD research, and veterans became visible participants and advocates within that movement.
The prominence of PTSD should not lead to the assumption that every veteran struggling after military service has PTSD or that every psychedelic treatment being studied for veterans is fundamentally a trauma treatment.
Depression Among Veterans
Depression can occur independently of PTSD or alongside it. Veterans may experience depression related to trauma, physical injuries, chronic pain, changes in identity, relationship disruption, isolation, or difficulty transitioning to civilian life.
Ketamine already has an established psychiatric role in treating certain forms of severe or treatment-resistant depression, while psilocybin is being actively studied for major depression and treatment-resistant depression. Those areas of research may ultimately become relevant to veteran mental health even when PTSD is not the primary diagnosis.
Anxiety Is Broader Than Trauma
Veterans can also experience generalized anxiety, panic symptoms, social anxiety, or anxiety associated with depression. These conditions may occur with PTSD, but they do not automatically mean someone has a trauma disorder.
Researchers are studying both psilocybin and ketamine across anxiety-related conditions, although the strength of evidence differs depending on the diagnosis. Our guide to Can Psychedelic Therapy Help Anxiety? explains why it is important not to collapse all anxiety symptoms into the PTSD category.
Grief, Loss, and Survivor Guilt
Military service can expose people to losses that are difficult to separate from the broader experience of service. The deaths of friends or fellow service members, survivor guilt, traumatic loss, and difficulty reconnecting with others afterward may contribute to grief that persists long after deployment ends.
Psychedelic research has increasingly explored themes involving mortality, meaning, emotional processing, and acceptance. Direct research into psychedelic therapy for grief remains limited, but these areas of overlap make grief an important topic in broader discussions about veteran mental health.
What Is Moral Injury?
Moral injury describes psychological or emotional distress that may occur after participating in, witnessing, or failing to prevent events that conflict deeply with someone’s moral beliefs. It can involve guilt, shame, betrayal, loss of meaning, or a changed sense of identity.
Moral injury is not the same as PTSD, although the two can occur together. Someone can have profound distress related to moral injury without experiencing the fear-based symptoms that define many PTSD presentations.
Researchers and clinicians interested in psychedelic-assisted therapy have begun exploring whether experiences involving perspective, self-compassion, emotional connection, or meaning could eventually have relevance to moral injury. The evidence remains developing.
Substance Use and Addiction
Substance-use disorders can overlap with trauma, depression, chronic pain, sleep problems, and other challenges experienced by veterans. Psychedelic researchers are currently studying several compounds for addiction and substance-use disorders.
Psilocybin research has included alcohol and tobacco use, while other psychedelic compounds are being investigated in different contexts. These approaches remain experimental and should not be viewed as replacements for established addiction treatment, but they represent another potential area in which psychedelic research may eventually intersect with veteran care.
Chronic Pain Complicates Mental Health
Many veterans also live with chronic pain or physical injuries. Pain can affect sleep, mood, relationships, substance use, and overall quality of life, making it difficult to separate physical health from mental health.
Ketamine is especially interesting in this context because it has applications in both pain medicine and psychiatry. That does not mean ketamine is a general treatment for every veteran with chronic pain, but it illustrates why the future of psychedelic-related care may involve more complex clinical decision-making than simply matching one psychedelic to one diagnosis.
Why “Psychedelic Therapy for Veterans” Is Too Broad
MDMA, psilocybin, and ketamine are different treatments with different evidence, different legal status, and different therapeutic models. A veteran with severe PTSD may need a completely different treatment approach from someone whose primary difficulty is depression, alcohol use disorder, prolonged grief, or moral injury.
If psychedelic-assisted therapies become more widely available, patient selection and accurate diagnosis will matter far more than whether someone belongs to the broad category of “veteran.”
Clinical Trials Will Help Define the Future
Much of what researchers still need to learn will come through carefully designed clinical trials. Studies can help clarify which conditions respond, which patients are appropriate candidates, how treatments should be combined with psychotherapy, what risks exist, and whether improvements last.
Veterans interested in participating in research can learn more through our guide to psychedelic clinical trials in California.
The Larger Picture
Veterans helped bring psychedelic-assisted therapy into the national conversation through research and advocacy surrounding PTSD, but the next phase of the field may be broader. Depression, anxiety, grief, substance use, chronic pain, moral injury, and other challenges do not disappear simply because someone does not meet criteria for PTSD.
The future of psychedelic therapy is therefore unlikely to be about one drug treating one diagnosis. It will be about understanding which treatments, therapeutic structures, and patients actually fit together—and where psychedelic-assisted approaches genuinely add value to existing mental health care.
Learn More About Psychedelic Therapy in California
Whether you’re exploring treatment options or looking for information specific to your region, continue your research with these guides.
Treatment Guides
- MDMA Therapy in California
- Psilocybin Therapy in California
- Ketamine Therapy
- Psychedelic Integration Therapy
- Psychedelic Clinical Trials California
Regional Guides
- Bay Area Psychedelic Therapy Guide
- Los Angeles Psychedelic Therapy Guide
- Orange County Psychedelic Therapy Guide
- San Diego Psychedelic Therapy Guide
- Sacramento Psychedelic Therapy Guide
- San Jose Psychedelic Therapy Guide
- Silicon Valley Psychedelic Therapy Guide
- Inland Empire Psychedelic Therapy Guide
- Central Coast Psychedelic Therapy Guide